» Articles » PMID: 28491334

Increasing the Rate of Living Donor Kidney Transplantation in Ontario: Donor- and Recipient-Identified Barriers and Solutions

Overview
Publisher Sage Publications
Date 2017 May 12
PMID 28491334
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: To hear from living kidney donors and recipients about what they perceive are the barriers to living donor kidney transplantation, and how patients can develop and lead innovative solutions to increase the rate and enhance the experiences of living donor kidney transplantation in Ontario.

Sources Of Information: A one-day patient-led workshop on March 10th, 2016 in Toronto, Ontario.

Methods: Participants who were previously engaged in priority-setting exercises were invited to the meeting by patient lead, Sue McKenzie. This included primarily past kidney donors, kidney transplant recipients, as well as researchers, and representatives from renal and transplant health care organizations across Ontario.

Key Findings: Four main barriers were identified: lack of education for patients and families, lack of public awareness about living donor kidney transplantation, financial costs incurred by donors, and health care system-level inefficiencies. Several novel solutions were proposed, including the development of a peer network to support and educate patients and families with kidney failure to pursue living donor kidney transplantation; consistent reimbursement policies to cover donors' out-of-pocket expenses; and partnering with the paramedical and insurance industry to improve the efficiency of the donor and recipient evaluation process.

Limitations: While there was a diversity of experience in the room from both donors and recipients, it does not provide a complete picture of the living kidney donation process for all Ontario donors and recipients. The discussion was provincially focused, and as such, some of the solutions suggested may already be in practice or unfeasible in other provinces.

Implications: The creation of a patient-led provincial council was suggested as an important next step to advance the development and implementation of solutions to overcome patient-identified barriers to living donor kidney transplantation.

Citing Articles

Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study.

Wang L, Ertmann E, Feldman E, Kossoff M, Lu B, Lin J Kidney Med. 2025; 7(3):100951.

PMID: 39926410 PMC: 11804814. DOI: 10.1016/j.xkme.2024.100951.


Living Donor Candidates' Self-reported Health and Health Perceptions and Completion of Donor Evaluation: A Cohort Study.

Ku E, Legaspi S, Copeland T, Adey D, Whelan A, Roll G Kidney Med. 2024; 6(11):100909.

PMID: 39534796 PMC: 11554918. DOI: 10.1016/j.xkme.2024.100909.


Ethical challenges in organ transplantation for Syrian refugees in Türkiye.

Birtan D, Akpinar A BMC Med Ethics. 2024; 25(1):124.

PMID: 39488690 PMC: 11531150. DOI: 10.1186/s12910-024-01124-x.


Implementation of a One-Day Living Kidney Donor Assessment Clinic to Improve the Efficiency of the Living Kidney Donor Evaluation: Program Report.

Yohanna S, Naylor K, Sontrop J, Ribic C, Clase C, Miller M Can J Kidney Health Dis. 2024; 11:20543581241231462.

PMID: 38410167 PMC: 10896046. DOI: 10.1177/20543581241231462.


Impact of the COVID-19 pandemic on Canadian transplant journeys: a mixed methods study.

Fox D, Hall M, Thibodeau C, Coldwell K, Lauder L, Dewell S BMJ Open. 2023; 13(12):e068347.

PMID: 38040429 PMC: 10693860. DOI: 10.1136/bmjopen-2022-068347.


References
1.
Wolfe R, Ashby V, Milford E, Ojo A, Ettenger R, Agodoa L . Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341(23):1725-30. DOI: 10.1056/NEJM199912023412303. View

2.
Rabbat C, Thorpe K, Russell J, Churchill D . Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol. 2000; 11(5):917-922. DOI: 10.1681/ASN.V115917. View

3.
Whiting J, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M . Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives. Am J Transplant. 2004; 4(4):569-73. DOI: 10.1111/j.1600-6143.2004.00373.x. View

4.
Clarke K, Klarenbach S, Vlaicu S, Yang R, Garg A . The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant. 2006; 21(7):1952-60. DOI: 10.1093/ndt/gfl069. View

5.
Vlaicu S, Klarenbach S, Yang R, Dempster T, Garg A . Current Canadian initiatives to reimburse live organ donors for their non-medical expenses. Can J Public Health. 2008; 98(6):481-3. PMC: 6975869. View